50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Immunotherapy Treatment Options for Advanced Endometrial CancerHomepage for Patient Site for KEYTRUDA® (pembrolizumab)Homepage for Patient Site for KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa
AEO Score: 5/10
Monitoring for AI engine activity
In the Engagemii AEO index
#137,892 of 463,436 in Healthcare for AI visibility
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Immunotherapy Treatment Options for Advanced Endometrial CancerHomepage for Patient Site for KEYTRUDA® (pembrolizumab)Homepage for Patient Site for KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa just got measured.
5/10 means Immunotherapy Treatment Options for Advanced Endometrial CancerHomepage for Patient Site for KEYTRUDA® (pembrolizumab)Homepage for Patient Site for KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Immunotherapy Treatment Options for Advanced Endometrial CancerHomepage for Patient Site for KEYTRUDA® (pembrolizumab)Homepage for Patient Site for KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa
Learn about treatment options for certain types of advanced endometrial cancer. See what pMMR, dMMR, and MSI-H mean and find questions to ask your care team.
Key Topics
Details
Industry: Healthcare
advancedendometrialcancer.comAI Visibility Breakdown
5
Structured Data
9
Content Structure
6
Entity Clarity
2
E-E-A-T Signals
6
Technical AEO
3
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Immunotherapy Treatment Options for Advanced Endometrial CancerHomepage for Patient Site for KEYTRUDA® (pembrolizumab)Homepage for Patient Site for KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa.
Source & Attribution
Scored by Engagemii on July 15, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/advancedendometrialcancer
Cite this score: Engagemii (2026). "AEO Score for Immunotherapy Treatment Options for Advanced Endometrial CancerHomepage for Patient Site for KEYTRUDA® (pembrolizumab)Homepage for Patient Site for KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa." Retrieved from https://engagemii.com/aeo/brands/advancedendometrialcancer
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform